Market Value17,351,037,330
Total Holdings101
File Date2023-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARAV / Aravive, Inc.
CMPX / Compass Therapeutics, Inc.
NRIX / Nurix Therapeutics, Inc.
BLUE / bluebird bio, Inc.
NLTX / Neoleukin Therapeutics, Inc.
ATHA / Athira Pharma, Inc.
RNA / Avidity Biosciences, Inc.
Invitae Corporation / Note 1.5% 4/1/2028 (46185LAD5)
Invitae Corporation / Series A 4.5% 3/15/2028 (46185LAH6)
DICE / DICE Therapeutics Inc
HOOK / HOOKIPA Pharma Inc.
DAWN / Day One Biopharmaceuticals, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
PNT / POINT Biopharma Global Inc.
VOR / Vor Biopharma Inc.
LPTX / Leap Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc.
SANA / Sana Biotechnology, Inc.
ABCL / AbCellera Biologics Inc.
KDNY / Chinook Therapeutics Inc
PRAX / Praxis Precision Medicines, Inc.
MRSN / Mersana Therapeutics, Inc.
FHTX / Foghorn Therapeutics Inc.
ITOS / iTeos Therapeutics, Inc.
ISR / Perspective Therapeutics Inc
IMGN / ImmunoGen, Inc.
MGNX / MacroGenics, Inc.
TCRX / TScan Therapeutics, Inc.
TSVT / 2seventy bio, Inc.
INSM / Insmed Incorporated
IDYA / IDEAYA Biosciences, Inc.
INCY / Incyte Corporation
CERS / Cerus Corporation
TLIS / Talis Biomedical Corporation
AVTE / Aerovate Therapeutics, Inc.
IMCR / Immunocore Holdings plc - Depositary Receipt (Common Stock)
KOD / Kodiak Sciences Inc.
DNLI / Denali Therapeutics Inc.
ROIV / Roivant Sciences Ltd.
CABA / Cabaletta Bio, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
XENE / Xenon Pharmaceuticals Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
TARA / Protara Therapeutics, Inc.
AGLE / Aeglea BioTherapeutics Inc
SRZNW / Surrozen, Inc. - Equity Warrant
OPT / Opthea Limited - Depositary Receipt (Common Stock)
KRYS / Krystal Biotech, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
KYMR / Kymera Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AFMD / Affimed N.V.
EWTX / Edgewise Therapeutics, Inc.
FGEN / FibroGen, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
ARGX / argenx SE - Depositary Receipt (Common Stock)
US64049K2033 / Neoleukin Therapeutics, Inc.
PMVP / PMV Pharmaceuticals, Inc.
GERN / Geron Corporation
XNCR / Xencor, Inc.
TNGX / Tango Therapeutics, Inc.
TSHA / Taysha Gene Therapies, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
ARVN / Arvinas, Inc.
BMEA / Biomea Fusion, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
IMTX / Immatics N.V.
SERA / Sera Prognostics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
PRME / Prime Medicine, Inc.
PRLD / Prelude Therapeutics Incorporated
ALGS / Aligos Therapeutics, Inc.
AADI / Aadi Bioscience, Inc.
VINC / Vincerx Pharma, Inc.
ALEC / Alector, Inc.
STOK / Stoke Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
DSGN / Design Therapeutics, Inc.
NKTX / Nkarta, Inc.
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
VERA / Vera Therapeutics, Inc.
SGMT / Sagimet Biosciences Inc.
IMVT / Immunovant, Inc.
MORF / Morphic Holding, Inc.
HRTX / Heron Therapeutics, Inc.
IPSC / Century Therapeutics, Inc.
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
TIL / Instil Bio, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
ALLO / Allogene Therapeutics, Inc.
TRDA / Entrada Therapeutics, Inc.
GRCL / Gracell Biotechnologies Inc. - Depositary Receipt (Common Stock)
FATE / Fate Therapeutics, Inc.
CELC / Celcuity Inc.
RVMD / Revolution Medicines, Inc.
BCEL / Atreca, Inc.
ANAB / AnaptysBio, Inc.
GLUE / Monte Rosa Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
AKRO / Akero Therapeutics, Inc.
SMMT * / Summit Therapeutics Inc.
VERV / Verve Therapeutics, Inc.
REPL / Replimune Group, Inc.
KALA / KALA BIO, Inc.
SPRY / ARS Pharmaceuticals, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
NVTA / Invitae Corporation
BMRN / BioMarin Pharmaceutical Inc.
PACB / Pacific Biosciences of California, Inc.
MRTX / Mirati Therapeutics, Inc.
NTRA / Natera, Inc.
VSTM / Verastem, Inc.